Depression of lymphocyte reactivity to phytohemagglutinin by serum from patients with liver disease.
D001647:Bile Acids and Salts; D002353:Carrier State; D056486:Chemical and Drug Induced Liver Injury; D002769:Cholelithiasis / Q000276:immunology; D006221:Halothane / Q000009:adverse effects; D006506:Hepatitis A / Q000276:immunology; D006511:Hepatitis B Antigens; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology*; D007165:Immunosuppression Therapy; D037102:Lectins / Q000494:pharmacology*; D008107:Liver Diseases / Q000276:immunology*; D008213:Lymphocyte Activation; D010190:Pancreatic Neoplasms / Q000276:immunology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D001647:Bile Acids and Salts; D006511:Hepatitis B Antigens; D007106:Immune Sera; D037102:Lectins; D014316:Tritium; D006221:Halothane; D013936:Thymidine